Reported relationships
Latest disclosed role at each company.
| Company | Last reported as | Report date | Published |
|---|---|---|---|
| Stabilis Solutions, Inc.SLNG · Entity 6659 | Director | September 09, 2026 | September 10, 2026 |
| U S PHYSICAL THERAPY INC /NVUSPH · Entity 379 | Director | May 15, 2024 | May 16, 2024 |
Disclosed balances
About these balances
Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.
Stabilis Solutions, Inc.
Report date September 09, 2026 · Filed September 10, 2026
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 74,839 |
Reported balance
After 2026-09-09 transaction · row 1
1 source rowRow 1 · 2026-09-09 · Purchase · Acquired 5,000 · Balance 74,839 |
U S PHYSICAL THERAPY INC /NV
Report date May 15, 2024 · Filed May 16, 2024
| Security / award | Ownership account | Disclosed shares / units | Disclosure context |
|---|---|---|---|
| Common StockSEC Table I · non-derivative | Direct | 3,280 |
Reported balance
After 2024-05-15 transaction · row 1
1 source rowRow 1 · 2024-05-15 · Sale · Disposed 2,500 · Balance 3,280 F1: The price reported ($107.57) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $107.15 to $108.09 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. |
Filing footnotes · ownership attribution and instrument terms
F1: The price reported ($107.57) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $107.15 to $108.09 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4.
Transaction history
JSON APIPurchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Company | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| September 09, 2026 Filed Sep 10, 2026 20:22 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 5,000 | $5.41 | $27,050.00 |
DisclosureSEC source: 0001437749-26-030079 · rdgdoc.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 74,839 Read SEC document |
| May 13, 2026 Filed May 14, 2026 12:42 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 7,500 | $3.89 | $29,175.00 |
DisclosureSEC source: 0001437749-26-016891 · rdgdoc.xml · nonDerivative · entry 2 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 69,839 Read SEC document |
| May 12, 2026 Filed May 14, 2026 12:42 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 167 | $3.60 | $601.20 |
DisclosureSEC source: 0001437749-26-016891 · rdgdoc.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,339 Read SEC document |
| February 28, 2025 Filed Feb 28, 2025 21:14 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 4,000 | $5.06 | $20,240.00 |
DisclosureSEC source: 0001437749-25-005723 · rdgdoc.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,172 Read SEC document |
| May 15, 2024 Filed May 16, 2024 21:14 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,500 | $107.57 | $268,925.00 |
DisclosureSEC source: 0000950170-24-061197 · ownership.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 3,280 F1 · price: The price reported ($107.57) is the weighted average price. The shares were sold in multiple transactions at prices ranging from $107.15 to $108.09 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| March 04, 2024 Filed Mar 5, 2024 23:10 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,500 | $104.26 | $260,650.00 |
DisclosureSEC source: 0000950170-24-026459 · ownership.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 5,780 F1 · price: This price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $104.00 to $104.80 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 400 shares which were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares on April 1, 2024, if he is a director of the Company on those dates. Read SEC document |
| November 13, 2023 Filed Nov 14, 2023 13:45 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 5,000 | $4.91 | $24,550.00 |
DisclosureSEC source: 0001437749-23-031774 · rdgdoc.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 58,172 Read SEC document |
| August 14, 2023 Filed Aug 14, 2023 21:07 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $107.60 | $107,600.00 |
DisclosureSEC source: 0001209191-23-045675 · doc4.xml · nonDerivative · entry 2 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 8,280 F1 · balance_after: Includes 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on October 1, 2023, January 1, 2024 and April 1, 2024, if he is a director of the Company on those dates. Read SEC document |
| August 11, 2023 Filed Aug 14, 2023 21:07 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,000 | $109.95 | $109,950.00 |
DisclosureSEC source: 0001209191-23-045675 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 9,280 F1 · balance_after: Includes 1,200 shares of common stock that were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on October 1, 2023, January 1, 2024 and April 1, 2024, if he is a director of the Company on those dates. Read SEC document |
| May 26, 2023 Filed May 30, 2023 20:13 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 7,000 | $3.87 | $27,090.00 |
DisclosureSEC source: 0001628280-23-020111 · wf-form4_168547758271371.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 53,172 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.86 to $3.87. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2023 Filed May 18, 2023 20:57 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-030669 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 10,280 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2023, October 1, 2023, January 1, 2024 and April 1, 2023, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| March 13, 2023 Filed Mar 14, 2023 20:32 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 7,000 | $3.63 | $25,410.00 |
DisclosureSEC source: 0001628280-23-007869 · wf-form4_167882590225540.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 46,172 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.596 to $3.66. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| August 15, 2022 Filed Aug 17, 2022 13:04 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 5,006 | $4.37 | $21,876.22 |
DisclosureSEC source: 0001628280-22-023103 · wf-form4_166074146440925.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 39,172 F1 · price: This transaction was executed in multiple trades at prices ranging from $4.25 to $4.37 on 8/15 and 8/16. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| May 16, 2022 Filed May 18, 2022 15:49 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-029943 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 8,680 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2022, October 1, 2022, January 1, 2023 and April 1, 2023, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| May 11, 2022 Filed May 11, 2022 20:48 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 1,000 | $4.16 | $4,160.00 |
DisclosureSEC source: 0001628280-22-013860 · wf-form4_165230211595528.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 34,166 Read SEC document |
| May 09, 2022 Filed May 9, 2022 21:36 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 5,000 | $4.13 | $20,650.00 |
DisclosureSEC source: 0001628280-22-013393 · wf-form4_165213215030613.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 33,166 F1 · price: This transaction was executed in multiple trades at prices ranging from $3.9 to $4.34. The price reported above reflects the weighted average sale price. The reporting person hereby undertakes to provide upon request to the SEC staff, the issuer or a security holder of the issuer full information regarding the number of shares and prices at which the transaction was effected. Read SEC document |
| March 15, 2022 Filed Mar 15, 2022 22:20 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 4,700 | $4.22 | $19,834.00 |
DisclosureSEC source: 0001628280-22-006305 · wf-form4_164738280187375.xml · nonDerivative · entry 2 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 28,166 Read SEC document |
| March 14, 2022 Filed Mar 15, 2022 22:20 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 400 | $4.60 | $1,840.00 |
DisclosureSEC source: 0001628280-22-006305 · wf-form4_164738280187375.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,466 Read SEC document |
| May 17, 2021 Filed May 19, 2021 15:31 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,480 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-21-033892 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,080 F1 · shares: The 1,480 shares of common stock was granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 370 shares lapsed on each of July 1, 2021, October 1, 2021, January 1, 2022 and April 1, 2022, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,480 shares of restricted stock granted under the Company equity plans mentioned in Note 1. Read SEC document |
| March 15, 2021 Filed Mar 16, 2021 12:56 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,600 | $121.73 | $194,768.00 |
DisclosureSEC source: 0001209191-21-020659 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $121.61 to $122.37 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 400 shares of restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares on April 1, 2021, if he is a director of the Company on those dates. Read SEC document |
| August 18, 2020 Filed Aug 19, 2020 13:40 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-20-047419 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,200 F1 · shares: The 1,600 shares of common stock were granted as restricted stock pursuant to the Company Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse for 400 shares upon grant and 400 shares on each of October 1, 2020 and January 1 and April 1, 2021, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares noted in above footnote. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 02:09 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | GrantRestricted Stock Units · Derivative | 13,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001043186-20-000007 · wf-form4_158164616533111.xml · derivative · entry 3 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 13,624 Underlying: Common Stock · 13,624 shares Expires not disclosed F2 · derivative.exercise_price: Each RSU represents the right to receive upon vesting, one share of Stabilis Energy, Inc. Common Stock. F2 · price: Each RSU represents the right to receive upon vesting, one share of Stabilis Energy, Inc. Common Stock. F3 · derivative.exercise_date: The RSUs were awarded to the reporting person pursuant to the LTIP and vest one year from the grant date, subject to the terms and conditions of the award agreement. F4 · derivative.expiration_date: Unless earlier forfeited under the terms and conditions of the award agreement, the RSUs expire immediately following vesting. Read SEC document |
| February 12, 2020 Filed Feb 14, 2020 02:09 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | GrantCommon Stock | 6,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001043186-20-000007 · wf-form4_158164616533111.xml · nonDerivative · entry 2 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,442 F1 · kind: The Restricted Stock Units ("RSUs") were awarded to the reporting person pursuant to the Stabilis Energy, Inc. 2019 Long Term Incentive Plan (the "LTIP") and vested immediately. Read SEC document |
| February 12, 2020 Filed Apr 17, 2020 15:56 UTC Amendment | Stabilis Solutions, Inc. SLNG · Entity 6659 | GrantCommon Stock | 13,624 | $0.00 | $0.00 |
DisclosureSEC source: 0001043186-20-000022 · wf-form4a_158713895262937.xml · nonDerivative · entry 3 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 23,066 F2 · kind: Represents shares of time based restricted stock granted under the LTIP, which will vest on February 12, 2021, subject to the terms and conditions of the award agreement. Read SEC document |
| February 12, 2020 Filed Apr 17, 2020 15:56 UTC Amendment | Stabilis Solutions, Inc. SLNG · Entity 6659 | GrantCommon Stock | 6,812 | $0.00 | $0.00 |
DisclosureSEC source: 0001043186-20-000022 · wf-form4a_158713895262937.xml · nonDerivative · entry 2 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 9,442 F1 · kind: The shares of restricted stock were awarded to the reporting person pursuant to the Stabilis Energy, Inc. 2019 Long Term Incentive Plan (the "LTIP") and vested immediately. Read SEC document |
| February 11, 2020 Filed Feb 14, 2020 02:09 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | GrantCommon Stock | 2,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001043186-20-000007 · wf-form4_158164616533111.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,630 F1 · kind: The Restricted Stock Units ("RSUs") were awarded to the reporting person pursuant to the Stabilis Energy, Inc. 2019 Long Term Incentive Plan (the "LTIP") and vested immediately. Read SEC document |
| February 11, 2020 Filed Apr 17, 2020 15:56 UTC Amendment | Stabilis Solutions, Inc. SLNG · Entity 6659 | GrantCommon Stock | 2,380 | $0.00 | $0.00 |
DisclosureSEC source: 0001043186-20-000022 · wf-form4a_158713895262937.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 2,630 F1 · kind: The shares of restricted stock were awarded to the reporting person pursuant to the Stabilis Energy, Inc. 2019 Long Term Incentive Plan (the "LTIP") and vested immediately. Read SEC document |
| November 21, 2019 Filed Nov 22, 2019 15:48 UTC | Stabilis Solutions, Inc. SLNG · Entity 6659 | PurchaseCommon Stock | 250 | $4.99 | $1,247.50 |
DisclosureSEC source: 0001043186-19-000016 · wf-form4_157443771794598.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 250 Read SEC document |
| May 20, 2019 Filed May 22, 2019 19:05 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 1,600 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-19-031987 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,600 F1 · shares: The 1,600 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 400 shares lapsed on each of July 1, 2019, October 1, 2019, January 1, 2020 and April 1, 2020, if he is a director of the Company on those dates. F2 · balance_after: Includes the 1,600 shares discussed in Note 1. Read SEC document |
| May 03, 2019 Filed May 6, 2019 16:39 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 1,750 | $115.22 | $201,635.00 |
DisclosureSEC source: 0001209191-19-027647 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 4,000 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $115.00 to $115.36 per share, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc. any of its shareholders or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| May 22, 2018 Filed May 23, 2018 17:59 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-18-032524 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 F1 · shares: The 2,000 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapse as to 500 shares lapsed on each of July 1, 2018, October 1, 2018, January 1, 2019 and April 1, 2019, if he is a director of the Company on those dates. F2 · balance_after: Includes the 2,000 shares discussed in Note 1. Read SEC document |
| May 11, 2018 Filed May 14, 2018 16:38 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $92.02 | $184,040.00 |
DisclosureSEC source: 0001209191-18-029750 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 3,750 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $91.90 - $92.25, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. Read SEC document |
| November 17, 2017 Filed Nov 20, 2017 15:26 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,000 | $68.72 | $137,440.00 |
DisclosureSEC source: 0001209191-17-061687 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.60 - $68.85, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,000 shares of common stock granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapsed as to 500 shares on January 1, 2018 and as to 500 shares on April 1, 2018, if Mr. Kuntz is a director of the Company on those dates. Read SEC document |
| October 03, 2017 Filed Oct 4, 2017 19:55 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | GrantCommon Stock | 2,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-17-055731 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 7,750 F1 · shares: The 2,000 shares of common stock was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restrictions lapsed as to 1,000 on the date of grant, October 3, 2017, for the remaining 1,000 shares 500 will lapse on each of January 1, 2018, and April 1, 2018, if he is a director of the Company on those dates. F2 · balance_after: Includes the 2,000 shares discussed in Note 1. Read SEC document |
| December 09, 2016 Filed Dec 12, 2016 20:18 UTC | U S PHYSICAL THERAPY INC /NV USPH · Entity 379 | SaleCommon Stock | 2,500 | $68.40 | $171,000.00 |
DisclosureSEC source: 0001209191-16-154666 · doc4.xml · nonDerivative · entry 1 KUNTZ EDWARD L · CIK 0001182168 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 5,750 F1 · price: The price reported is a weighted average price. The shares were sold in multiple transactions at prices ranging from $68.30 - $68.60, both inclusive. The reporting person undertakes to provide to U.S. Physical Therapy, Inc., any of its shareholders or the staff of the Securities & Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote to this Form 4. F2 · balance_after: Includes 1,250 shares of common stock which was granted as restricted stock pursuant to the Company's Amended and Restated 2003 Stock Incentive Plan. Restricted lapse as to 625 shares on each of January 1, 2017 and April 1, 2017. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.